[1]
“ A new methodology for polyvalent intravenous immunoglobulin solution production with a two-stage process of viral inactivation ”, Braz. J. Pharm. Sci., vol. 46, no. 4, pp. 777–783, Dec. 2010, doi: 10.1590/S1984-82502010000400020.